Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Halogenated Coumarin–Chalcones as Multifunctional Monoamine Oxidase-B and Butyrylcholinesterase Inhibitors
Nisha Abdul Rehuman, Jong‐Min Oh, Lekshmi R. Nath, et al.
ACS Omega (2021) Vol. 6, Iss. 42, pp. 28182-28193
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Coumarin hybrids for targeted therapies: A promising approach for potential drug candidates
Nameer Mazin Zeki, Yasser Fakri Mustafa
Phytochemistry Letters (2024) Vol. 60, pp. 117-133
Closed Access | Times Cited: 15
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 43
Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma
Narayan D. Chaurasiya, Francisco León, Ilias Muhammad, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4297-4297
Open Access | Times Cited: 40
Recent advances on biologically active coumarin-based hybrid compounds
Metin Yıldırım, Samet Poyraz, Mehmet Erşatır
Medicinal Chemistry Research (2023) Vol. 32, Iss. 4, pp. 617-642
Closed Access | Times Cited: 35
Halogenated Antimicrobial Agents to Combat Drug-Resistant Pathogens
Olajide Sunday Faleye, Bharath Reddy Boya, Jin-Hyung Lee, et al.
Pharmacological Reviews (2023) Vol. 76, Iss. 1, pp. 90-141
Open Access | Times Cited: 35
New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands
Tian‐Yu Sun, Tengfei Zhen, Chrisanta Hamis Harakandi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116569-116569
Closed Access | Times Cited: 9
Coumarin hybrids: a sighting of their roles in drug targeting
Nameer Mazin Zeki, Yasser Fakri Mustafa
Chemical Papers (2024) Vol. 78, Iss. 10, pp. 5753-5772
Closed Access | Times Cited: 7
Development of bromo- and fluoro-based α, β-unsaturated ketones as highly potent MAO-B inhibitors for the treatment of Parkinson's disease
Mohamed A. Abdelgawad, Jong‐Min Oh, Della Grace Thomas Parambi, et al.
Journal of Molecular Structure (2022) Vol. 1266, pp. 133545-133545
Closed Access | Times Cited: 33
Introduction of benzyloxy pharmacophore into aryl/heteroaryl chalcone motifs as a new class of monoamine oxidase B inhibitors
Sachithra Thazhathuveedu Sudevan, Jong‐Min Oh, Mohamed A. Abdelgawad, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Terminators or Guardians? Design, Synthesis, and Cytotoxicity Profiling of Chalcone-Sulfonamide Hybrids
Shaimaa M. Aboukhatwa, Peter A. Sidhom, Andrea Angeli, et al.
ACS Omega (2023) Vol. 8, Iss. 8, pp. 7666-7683
Open Access | Times Cited: 19
Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease
Da-Jiang Zou, Renzheng Liu, Yangjing Lv, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 18
Design, synthesis, biological evaluation, and in silico studies of imidazo[2,1-b][1,3,4]thiadiazole derivatives as cholinesterase inhibitors
Wen-Rong Du, Yixuan Wang, Xue-Wei Zhou, et al.
Medicinal Chemistry Research (2025)
Closed Access
Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions
Slobodan Rendić, Rachel D. Crouch, F. Peter Guengerich
Archives of Toxicology (2022) Vol. 96, Iss. 8, pp. 2145-2246
Open Access | Times Cited: 24
Dual-Target Inhibitors Based on Acetylcholinesterase: Novel Agents for Alzheimer's Disease
Xingyi Zhao, Qiaoguan Hu, Xiaoqian Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116810-116810
Closed Access | Times Cited: 4
Chalcones as Potential Ligands for the Treatment of Parkinson’s Disease
Ewelina Królicka, Katarzyna Kieć‐Kononowicz, Dorota Łażewska
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 847-847
Open Access | Times Cited: 20
A structural approach to investigate halogen substituted MAO-B inhibitors using QSAR modeling, molecular dynamics, and conceptual DFT analysis
Naseer Maliyakkal, Iqrar Ahmad, Sunil Kumar, et al.
Journal of Saudi Chemical Society (2023) Vol. 27, Iss. 4, pp. 101675-101675
Open Access | Times Cited: 11
Recent Developments in Coumarin Derivatives as Neuroprotective Agents
Prakash Shyambabu Mishra, Amit Kumar, Kamalpreet Kaur, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 35, pp. 5702-5738
Closed Access | Times Cited: 10
Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer’s Diseases: Emerging Paradigms and Strategies
Narayanaperumal Pravin, Krzysztof Jóźwiak
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6085-6085
Open Access | Times Cited: 17
Natural and Semi-Synthetic Flavonoid Anti-SARS-CoV-2 Agents for the Treatment of Long COVID-19 Disease and Neurodegenerative Disorders of Cognitive Decline
James Melrose, Margaret M. Smith
Frontiers in Bioscience-Elite (2022) Vol. 14, Iss. 4, pp. 27-27
Open Access | Times Cited: 16
Conjugated Dienones from Differently Substituted Cinnamaldehyde as Highly Potent Monoamine Oxidase-B Inhibitors: Synthesis, Biochemistry, and Computational Chemistry
Bijo Mathew, Jong‐Min Oh, Mohamed A. Abdelgawad, et al.
ACS Omega (2022) Vol. 7, Iss. 9, pp. 8184-8197
Open Access | Times Cited: 15
Two dimensional-QSAR and molecular dynamics studies of a selected class of aldoxime- and hydroxy-functionalized chalcones as monoamine oxidase-B inhibitors
Bijo Mathew, Ravichandran Veerasamy, Seenivasan Raghuraman, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 19, pp. 9256-9266
Closed Access | Times Cited: 15
Neuroprotection induced by coumarins in central nervous system disease models
Suzana Braga de Souza, Rafael Short Ferreira, Cleonice Creusa dos Santos, et al.
Elsevier eBooks (2024), pp. 1411-1440
Closed Access | Times Cited: 2
Inhibition of monoamine oxidases by heterocyclic derived conjugated dienones: synthesis, in vitro, and in silico investigations
Sunil Kumar, Bishnu Prasad Pandey, Mohamed A. Abdelgawad, et al.
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Development of Halogenated-Chalcones Bearing with Dimethoxy Phenyl Head as Monoamine Oxidase-B Inhibitors
Nisha Abdul Rehuman, Jong‐Min Oh, Mohamed A. Abdelgawad, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1152-1152
Open Access | Times Cited: 13
Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson’s disease: Synthesis, biochemistry, and molecular dynamics study
Della Grace Thomas Parambi, Jong‐Min Oh, Sunil Kumar, et al.
Computational Biology and Chemistry (2023) Vol. 105, pp. 107899-107899
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top